Press release
Gilead Showcases Latest HIV Pipeline Progress and the Impact of Global Collaboration on Health Equity Efforts at IAS 2023
– Key Initiatives Highlight the Role of Catalytic Collaboration to Help Advance Health Equity – – Latest HIV Research and Development Data Drive the Next
About this update from Gilead Sciences, Inc.
[{"type":"text","content":"\n– Key Initiatives Highlight the Role of Catalytic Collaboration to Help Advance Health Equity –\n\n\n– Latest HIV Research and Development Data Drive the Next Wave of Person-Centric Scientific Discovery in Treatment, Prevention and Novel Research Strategies in HIV Cure –\n\n\n FOSTER CITY, Calif.--(BUSINESS WIRE)--\nGilead Sciences, Inc. (Nasdaq: GILD) today announced its upcoming contributions to the 12th International AIDS Society Conference on HIV Science (IAS 2023), taking place in Brisbane, Australia, and virtually, from July 23-26, 2023. As the leader in HIV innovation, Gilead will provide updates on its signature initiatives and key collaborations while sharing new scientific data from its research and development programs. The breadth of data presented at the meeting, along with Gilead-led symposia, reflect its innovative approach to advancing HIV prevention, treatment and cure strategies and underscore Gilead’s focus on forming partnerships with communities worldwide as part of its unequivocal commitment to help end the HIV epidemic for everyone, everywhere.\n\n\n“HIV will remain a global epidemic so long as people and communities do not have access to HIV care, services and innovative and life-saving medicines due to structural and social inequalities,” said Alex Kalomparis, Senior Vice President, Public Affairs, Gilead Sciences. “At Gilead, our efforts at the global, national and local levels aim to reduce these disparities, with an emphasis on eliminating stigma and discrimination, ensuring equitable access to people-centered HIV care and services, and forging industry-leading partnerships that expand global access to our innovative and life-saving medicines. During IAS 2023, we look forward to sharing the latest from our ongoing health equity efforts and launching a new community-based initiative that seeks to change the future of the HIV epidemic.”\n\n\nAdvancing Efforts to Address Barriers to HIV Care and Prevention\n\n\nAt IAS 2023, Gilead will convene two symposia to discuss the latest progress in policies and practical solutions from around the world to help achieve more equitable access to HIV care and services.\n\n\nIgnite change: Championing HIV status-neutral care together (July 23, 3:00pm AEST), will feature an international multidisciplinary expert panel exploring how a status-neutral approach can impro...